|
1
|
Cao W, Wang X and Li JC: Hereditary breast
cancer in the Han Chinese population. J Epidemiol. 23:75–84. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Assadi M, Lamerz J, Jarutat T, et al:
Multiple protein analysis of formalin-fixed and paraffin-embedded
tissue samples with reverse phase protein arrays. Mol Cell
Proteomics. 12:2615–2622. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Asghar U, Witkiewicz AK, Turner NC and
Knudsen ES: The history and future of targeting cyclin-dependent
kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Atalay C: New concepts in axillary
management of breast cancer. World J Clin Oncol. 5:895–900. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh R and Mo YY: Role of microRNAs in
breast cancer. Cancer Biol Ther. 14:201–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Redova M, Sana J and Slaby O: Circulating
miRNAs as new blood-based biomarkers for solid cancers. Future
Oncol. 9:387–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pinho FG, Frampton AE, Nunes J, et al:
Downregulation of microRNA-515-5p by the estrogen receptor
modulates sphingosine kinase 1 and breast cancer cell
proliferation. Cancer Res. 73:5936–5948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hwang MS, Yu N, Stinson SY, et al:
miR-221/222 targets adiponectin receptor 1 to promote the
epithelial-to-mesenchymal transition in breast cancer. PloS One.
8:e665022013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang IC, Chen YJ, Hughes D, et al:
Forkhead box M1 regulates the transcriptional network of genes
essential for mitotic progression and genes encoding the SCF
(Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 25:10875–10894. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sansom SE, Nuovo GJ, Martin MM, Kotha SR,
Parinandi NL and Elton TS: miR-802 regulates human angiotensin II
type 1 receptor expression in intestinal epithelial C2BBe1 cells.
Am J Physiol Gastrointest Liver Physiol. 299:G632–G642. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kornfeld JW, Baitzel C, Konner AC, et al:
Obesity-induced overexpression of miR-802 impairs glucose
metabolism through silencing of Hnf1b. Nature. 494:111–115. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sengupta A, Kalinichenko VV and Yutzey KE:
FoxO1 and FoxM1 transcription factors have antagonistic functions
in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene
regulation. Circ Res. 112:267–277. 2013. View Article : Google Scholar :
|
|
15
|
Qu K, Xu X, Liu C, et al: Negative
regulation of transcription factor FoxM1 by p53 enhances
oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer
Lett. 331:105–114. 2013. View Article : Google Scholar
|
|
16
|
Sanders DA, Ross-Innes CS, Beraldi D,
Carroll JS and Balasubramanian S: Genome-wide mapping of FOXM1
binding reveals co-binding with estrogen receptor alpha in breast
cancer cells. Genome Biol. 14:R62013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang C, Chen H, Tan G, et al: FOXM1
promotes the epithelial to mesenchymal transition by stimulating
the transcription of Slug in human breast cancer. Cancer Lett.
340:104–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Halasi M, Pandit B, Wang M, Nogueira V,
Hay N and Gartel AL: Combination of oxidative stress and FOXM1
inhibitors induces apoptosis in cancer cells and inhibits xenograft
tumor growth. Am J Pathol. 183:257–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Wang Y, Luo J, et al: miR-134
inhibits epithelial to mesenchymal transition by targeting FOXM1 in
non-small cell lung cancer cells. FEBS Lett. 586:3761–3765. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ke Y, Zhao W, Xiong J and Cao R: miR-149
Inhibits non-small-cell lung cancer cells EMT by targeting FOXM1.
Biochem Res Int. 2013:5067312013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Feng Y, Wang L, Zeng J, et al: FoxM1 is
overexpressed in Helicobacter pylori-induced gastric carcinogenesis
and is negatively regulated by miR-370. Mol Cancer Res. 11:834–844.
2013. View Article : Google Scholar : PubMed/NCBI
|
